- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Battle of sexes begins in genes
Thousands of genes that behave differently in the same organs of males and females may help explain why the same disease often strikes males and females differently, and why the genders may not respond the same way to the same drug.
Thousands of genes that behave differently in the same organs of males and females may help explain why the same disease often strikes males and females differently, and why the genders may not respond the same way to the same drug.
Xia Yang, Ph.D., a postdoctoral fellow in cardiology at the University of California, Los Angeles, and colleagues examined brain, liver, fat, and muscle tissue from mice with the goal of finding genetic clues related to mental illnesses, diabetes, obesity, and atherosclerosis. The team scrutinized more than 23,000 genes. Even in the same organ, scores of genes varied in expression levels between the sexes (Genome Res 2006;16:995-1004).
"We share the same genetic code, but our findings imply that gender regulates how quickly the body can convert DNA to proteins," Yang said. "This suggests that gender influences how disease develops."
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
